- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Bayer AG NA (BAYN)
Bayer AG NA stock price live, this page displays ETR BAYGn stock exchange data. View the BAYGn premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Bayer AG NA real time stock price chart below.
What Is the Bayer AG NA Stock Price Today?
The Bayer AG NA stock price today is 122.8000.
What Is the Stock Symbol for Bayer AG NA?
The stock symbol for Bayer AG NA is ""BAYGn.""
What Stock Exchange Does Bayer AG NA Trade On?
Bayer AG NA is listed and trades on the Xetra stock exchange.
Is Bayer AG NA a Good Stock to Buy?
Determining whether Bayer AG NA—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BAYGn quote. (ISIN: DE000BAY0017)
What Is the Bayer AG NA Stock Price Today?
The Bayer AG NA stock price today is 122.8000.
What Is the Stock Symbol for Bayer AG NA?
The stock symbol for Bayer AG NA is ""BAYGn.""
What Stock Exchange Does Bayer AG NA Trade On?
Bayer AG NA is listed and trades on the Xetra stock exchange.
Is Bayer AG NA a Good Stock to Buy?
Determining whether Bayer AG NA—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BAYGn quote. (ISIN: DE000BAY0017)
Bucharest
Currency in RON
122.8000
+0.4400(+0.36%)
Closed·
Fair Value
An estimate of a Bayer AG NA's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
120.2800
125.7400
52 wk Range
93.0000
152.8000
BAYN is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a Bayer AG NA's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
120.2800125.7400
52 wk Range
93.0000152.8000
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
BAYN Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Bayer AG NA's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Currently not supported.
- Bayer BX receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Bayer BX receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- BAYER AG-Exch receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Bayer AG NA Company Profile
Bayer Aktiengesellschaft operates as a life science company worldwide. The company operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, medicated skincare products, nutritional supplements, pain and cardiovascular risk prevention products, digestive health products, allergy products, and cold and cough products. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solutions, and pest and weed management products, as well as customer services for agriculture. It also engages in the breeding, propagation, and production/processing of seeds, including seed dressing. The company distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft was founded in 1863 and is based in Leverkusen, Germany.
Bayer AG NA Earnings Call Summary for Q1/2025
- Q1 2025: Flat sales, core EPS at €2.49, EBITDA down 7%, free cash flow improved by €1B despite remaining negative
- Pharmaceutical innovations: BIANTRA launched in Germany, elenzanatant launch planned for H2 2025, Nubeqa and Corendia grew 80% YoY
- Maintained full-year guidance, pharmaceutical segment expected to perform at upper end of sales and profitability forecasts
- Ongoing restructuring includes significant workforce reductions; company focusing on innovative technologies to differentiate from generics
- Challenges: Generic pressure, crop protection market overcapacity, potential FX headwinds of €900M in net sales anticipated
Last Updated: 13/05/2025, 09:06
Read Full TranscriptCompare BAYN to Peers and Sector
Metrics to compare | BAYN | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipBAYNPeersSector | |
|---|---|---|---|---|
P/E Ratio | 0.0x | 17.2x | −0.5x | |
PEG Ratio | 0.00 | 0.25 | 0.00 | |
Price/Book | 0.0x | 2.2x | 2.6x | |
Price / LTM Sales | 0.0x | 2.3x | 3.2x | |
Upside (Analyst Target) | 0.0% | 37.0% | 42.0% | |
Fair Value Upside | Unlock | 30.9% | 6.6% | Unlock |
Earnings
Latest Release
May 13, 2025
EPS / Forecast
1.32 / --
Revenue / Forecast
13.74B / --
People Also Watch
FAQ
What Stock Exchange Does Bayer AG NA Trade On?
Bayer AG NA is listed and trades on the Bucharest Stock Exchange stock exchange.
What Is the Stock Symbol for Bayer AG NA?
The stock symbol for Bayer AG NA is "BAYN."
What Is the Bayer AG NA Market Cap?
As of today, Bayer AG NA market cap is 140.64B.
What Is Bayer AG NA's Earnings Per Share (TTM)?
The Bayer AG NA EPS (TTM) is -3.31.
From a Technical Analysis Perspective, Is BAYN a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Bayer AG NA Stock Split?
Bayer AG NA has split 0 times.
How Many Employees Does Bayer AG NA Have?
Bayer AG NA has 90885 employees.
What is the current trading status of Bayer AG NA (BAYN)?
As of 30 Jul 2025, Bayer AG NA (BAYN) is trading at a price of 122.80, with a previous close of 112.36. The stock has fluctuated within a day range of 120.28 to 125.74, while its 52-week range spans from 93.00 to 152.80.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.